학술논문
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.
Document Type
Article
Author
Source
Cell Death & Disease; Nov2023, Vol. 14 Issue 11, p1-12, 12p
Subject
Language
ISSN
20414889